tweenvest

Genenta Science S.p.A. (NasdaqCM: SAEN)

Health Care · Biotechnology · IT

$0.58

+0.85% today · -70.8% 1Y

Public summary
A free snapshot of Genenta Science S.p.A., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Genenta Science S.p.A. (NasdaqCM: SAEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $28.06M and employs 9 people.

Over the last twelve months the share price has lost 70.8%, trading between 0.55 and 2.58.

Tweenvest scores Genenta Science S.p.A. across four factors: quality 40/100, value 48/100. Its strongest factor is value.

SAEN price history

Nov 21, 2025 · 1.68Weekly closes 0.58 – 2.04Nov 18, 2026 · 0.58

Key figures

Market cap
$28.06M
Revenue (TTM)
—
P/E
-3.81
EPS
-0.39
Dividend yield
—
Beta (5Y)
0.77
52-week high
$2.58
52-week low
$0.55
Avg volume (3M)
—
Shares outstanding
48.22M
Employees
9
Next earnings
—

About Genenta Science S.p.A.

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

ISIN
US36870W1009
Founded
2014
Listed since
Dec 15, 2021
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Amplia Therapeutics LimitedASX: ATX$28.42MAU$0.08-1.20%
Microbix Biosystems Inc.TSX: MBX$28.29MCA$0.30+1.72%
Edesa Biotech, Inc.NasdaqCM: EDSA$28.10M$2.08-6.31%
ProMIS Neurosciences, Inc.NasdaqCM: PMN$28.07M$3.13-2.49%
Anti-Microbial Savior BioteQ Co., Ltd.TPEX: 6864$28.04MNT$37.00-1.07%
Immunotech Biopharm LtdSEHK: 6978$27.94MHK$0.36-1.39%
Polyrizon Ltd.NasdaqCM: PLRZ$27.88M$11.48+4.20%
Enimmune CorporationTPEX: 6564$27.48MNT$15.10+0.67%

Browse every Biotechnology company →